» Articles » PMID: 26431320

Intraovarian Transplantation of Female Germline Stem Cells Rescue Ovarian Function in Chemotherapy-Injured Ovaries

Overview
Journal PLoS One
Date 2015 Oct 3
PMID 26431320
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Early menopause and infertility often occur in female cancer patients after chemotherapy (CTx). For these patients, oocyte/embryo cryopreservation or ovarian tissue cryopreservation is the current modality for fertility preservation. However, the above methods are limited in the long-term protection of ovarian function, especially for fertility preservation (very few females with cancer have achieved pregnancy with cryopreserved ovarian tissue or eggs until now). In addition, the above methods are subject to their scope (females with no husband or prepubertal females with no mature oocytes). Thus, many females who suffer from cancers would not adopt the above methods pre- and post-CTx due to their uncertainty, safety and cost-effectiveness. Therefore, millions of women have achieved long-term survival after thorough CTx treatment and have desired to rescue their ovarian function and fertility with economic, durable and reliable methods. Recently, some studies showed that mice with infertility caused by CTx can produce normal offspring through intraovarian injection of exogenous female germline stem cells (FGSCs). Though exogenous FGSC can be derived from mice without immune rejection in the same strain, it is difficult to obtain human female germline stem cells (hFGSCs), and immune rejection could occur between different individuals. In this study, infertility in mice was caused by CTx, and the ability of FGSCs to restore ovarian function or even produce offspring was assessed. We had successfully isolated and purified the FGSCs from adult female mice two weeks after CTx. After infection with GFP-carrying virus, the FGSCs were transplanted into ovaries of mice with infertility caused by CTx. Finally, ovarian function was restored and the recipients produced offspring long-term. These findings showed that mice with CTx possessed FGSCs, restoring ovarian function and avoiding immune rejection from exogenous germline stem cells.

Citing Articles

Application of Mesenchymal Stem Cells in Female Infertility Treatment: Protocols and Preliminary Results.

Chatzianagnosti S, Dermitzakis I, Theotokis P, Kousta E, Mastorakos G, Manthou M Life (Basel). 2024; 14(9).

PMID: 39337944 PMC: 11433628. DOI: 10.3390/life14091161.


A bioengineered in situ ovary (ISO) supports follicle engraftment and live-births post-chemotherapy.

Buckenmeyer M, Sukhwani M, Iftikhar A, Nolfi A, Xian Z, Dadi S J Tissue Eng. 2023; 14:20417314231197282.

PMID: 38029018 PMC: 10656812. DOI: 10.1177/20417314231197282.


Characterization of Oogonial Stem Cells in Adult Mouse Ovaries with Age and Comparison to In Silico Data on Human Ovarian Aging.

MacDonald J, Sheehan H, Piasecki A, Faustino L, Hauschildt C, Stolzenbach V Stem Cells Dev. 2023; 32(5-6):99-114.

PMID: 36594561 PMC: 9986025. DOI: 10.1089/scd.2022.0284.


Revisiting Claims of the Continued Absence of Functional Germline Stem Cells in Adult Ovaries.

Woods D, Tilly J Stem Cells. 2022; 41(2):200-204.

PMID: 36472569 PMC: 9982064. DOI: 10.1093/stmcls/sxac083.


Non-neutral clonal selection and its potential role in mammalian germline stem cell dysfunction with advancing age.

Stolzenbach V, Woods D, Tilly J Front Cell Dev Biol. 2022; 10:942652.

PMID: 36081905 PMC: 9445274. DOI: 10.3389/fcell.2022.942652.


References
1.
Swerdlow A, Cooke R, Bates A, Cunningham D, Falk S, Gilson D . Risk of premature menopause after treatment for Hodgkin's lymphoma. J Natl Cancer Inst. 2014; 106(9). DOI: 10.1093/jnci/dju207. View

2.
Wan J, Gai Y, Li G, Tao Z, Zhang Z . Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer. Clin Colorectal Cancer. 2014; 14(1):31-4. DOI: 10.1016/j.clcc.2014.09.012. View

3.
White Y, Woods D, Takai Y, Ishihara O, Seki H, Tilly J . Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012; 18(3):413-21. PMC: 3296965. DOI: 10.1038/nm.2669. View

4.
Park E, Tilly J . Use of DEAD-box polypeptide-4 (Ddx4) gene promoter-driven fluorescent reporter mice to identify mitotically active germ cells in post-natal mouse ovaries. Mol Hum Reprod. 2014; 21(1):58-65. PMC: 4275040. DOI: 10.1093/molehr/gau071. View

5.
Lei L, Spradling A . Female mice lack adult germ-line stem cells but sustain oogenesis using stable primordial follicles. Proc Natl Acad Sci U S A. 2013; 110(21):8585-90. PMC: 3666718. DOI: 10.1073/pnas.1306189110. View